Published on: May 17, 2019 at 09:30PM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Tirzepatide;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Not yet recruiting
http://bit.ly/2WO4dsN

0 Comments